These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9152974)

  • 1. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
    Barbui T; Finazzi G; Falanga A
    Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
    [No Abstract]   [Full Text] [Related]  

  • 5. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.
    Tallman MS; Kwaan HC
    Blood; 1992 Feb; 79(3):543-53. PubMed ID: 1732003
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
    Kwaan HC; Cull EH
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic problems in acute promyelocytic leukaemia.
    Arbuthnot C; Wilde JT
    Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulopathy of acute promyelocytic leukaemia revisited.
    Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of acute promyelocytic leukemia in a 92-year-old man using all-trans retinoic acid combined with oral arsenic: A case report.
    Shi X; Li S; Tang S; Lu Y
    Medicine (Baltimore); 2021 Jun; 100(22):e26144. PubMed ID: 34087869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.